Pulsara Welcomes New Member to Board of Directors
Brian Webster, CEO of Kestra Medical Technologies, brings significant healthcare expertise to Pulsara’s Board of Directors
2 min read
James Woodson, MD
:
Mar 21, 2017
Bridging therapy made functional independence equally likely for stroke patients transported first to primary stroke centers without endovascular capabilities and peers taken straight to a comprehensive stroke center, a study showed.That strategy of IV thrombolysis within 4.5 hours of symptom onset at one center followed by transport to another where mechanical thrombectomy can be performed within 6 hours of symptom onset was just as likely to produce good functional outcomes 3 months later (modified Rankin scale scores of 2 or below) as transporting patients straight to a thrombectomy-capable center (61.0% versus 50.8%, P=0.26) -- even after multivariable adjustment (P=0.82).
"This study found that patients treated under the drip-and-ship paradigm also benefit from bridging therapy, with no statistically significant difference compared with those treated directly in a comprehensive stroke center," Sonia Alamowitch, MD, of Hôpital Saint-Antoine in Paris, and colleagues reported online in JAMA Neurology.
>> Continue reading.
In the article, Louis R. Caplan, MD, of Beth Israel Deaconess Medical Center in Boston also recommended several changes to all stroke centers:
Brian Webster, CEO of Kestra Medical Technologies, brings significant healthcare expertise to Pulsara’s Board of Directors
The mental health of America’s youth is under duress, and it didn’t start with COVID-19. It’s a problem that’s been a much longer time coming. In...
Imagine: In the midst of a pandemic, you're managing patient load across a state that covers over 261,000 square miles and is home to over 30 million...